New vaccine trial aims to protect against deadly meningitis
⭐️ VACCINE ⭐️
Recruiting now
This study is testing a new vaccine called GNG-DE to see if it safely protects people from four dangerous types of meningococcal bacteria (A, C, Y, W135). Researchers will compare it to an existing vaccine in 240 healthy volunteers aged 3 to 55. The main goal is to see if the new…
Phase: PHASE3 • Sponsor: NPO Petrovax • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 10, 2026 12:52 UTC